Navigation Links
Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors

Mooney Brings Wealth of Finance, Accounting and Industry Experience to

Kendle Board

CINCINNATI, Nov. 10 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the reappointment of Timothy M. Mooney to the Company's Board of Directors effective immediately. Mooney was Executive Vice President and Chief Financial Officer for Kendle from 1996 until his retirement in 2002, leading the Company's global financial operations, including finance, accounting, treasury, budgeting, taxes, mergers and acquisitions, investor relations and financial planning. He also served as a Director of the Company from 1997 to 2002. Mooney currently serves as Vice President of Operations at St. Xavier High School in Cincinnati. He brings nearly 40 years of accounting and finance experience to Kendle's Board and will serve as a member of the Audit Committee.

(Logo: )

"We are thrilled to welcome back Tim Mooney to Kendle's Board," said Chairman and Chief Executive Officer Candace Kendle, PharmD. "Tim played a pivotal role in leading Kendle's financial operations during our early years as a private and then public company and our emergence as a global provider of CRO services, and we look forward to having the benefit of his experience with us once again as part of our Board. His extensive background in finance and accounting and knowledge of our sector will serve us well as Kendle continues to accelerate its position as a leading provider of Phase I-IV clinical development services to biopharmaceutical companies worldwide."

Prior to Kendle, Mooney served as Vice President, Treasurer and Chief Financial Officer for The Future Now, Inc. and Senior Vice President and Chief Financial Officer for Hook-SupeRx, Inc. His experience also includes serving as a Partner with the public accounting firm Coopers & Lybrand. He currently serves on the Board of Directors of Regent Communications, Inc., a publicly traded radio broadcasting company headquartered in Covington, Ky. He is Chairman of Regent's Audit Committee and is a member of the Nominating and Corporate Governance Committee. Mooney also has served on the Board of Directors of Winton Financial Corp., and as Chairman of Winton's Audit Committee and as a member of its Compensation Committee. Mooney earned a bachelor of science in business administration from Xavier University in Cincinnati.

Mooney's appointment increases the number of Kendle directors from seven to eight and the number of independent directors from five to six. He joins Dr. Kendle and current board members Christopher C. Bergen, Chief Operating Officer, Kendle; Robert R. Buck, President and Chief Executive Officer, Beacon Roofing Supply, Inc.; G. Steven Geis, PhD, M.D., Retired, Group Vice President: Arthritis, Cardiovascular and Oncology Clinical Development, Pharmacia & Upjohn Company; Donald C. Harrison, M.D., Senior Vice President and Provost for Health Affairs Emeritus, University of Cincinnati; Timothy E. Johnson, PhD, President, Johnson Investment Counsel, Inc. and Professor of Finance, University of Cincinnati; and Frederick A. Russ, PhD, Senior Vice Provost, University of Cincinnati.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning 90 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Kendle was recognized by FORTUNE magazine as one of the 100 fastest-growing companies in the United States for 2008. The company also has been recognized as "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leading global pharmaceutical publication Scrip World Pharmaceutical News.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at

SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle Named a Best Place to Work in Greater Cincinnati
2. Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations
3. Kendle Named to FORTUNE List of 100 Fastest-Growing Companies for 2008
4. Kendle to Present at the UBS Global Life Sciences Conference
5. Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call and Webcast
6. Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress
7. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
8. Kendle Appoints Patricia Williams Vice President, Commercial Operations
9. Kendle Invites You to Attend its First Quarter 2008 Earnings Conference Call and Webcast
10. Kendle to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
11. Kendle Leaders Adopt 10b5-1 Trading Plans
Post Your Comments:
(Date:11/30/2015)... ... , ... Global Stem Cells Group Chile CEO ... America and abroad for the first Iberoamerican Convention on Aesthetic Medicine, Cosmetology and ... will present and discuss new trends in anti-aging stem cell treatments, regenerative medicine ...
(Date:11/30/2015)... ... 30, 2015 , ... Global Stem Cells Group announced the opening of a new ... Arica and Iquique in northern Chile. The facilities are part of GSCG’s expansion efforts in ... and techniques in stem cell medicine to patients from around the world. , The clinics ...
(Date:11/30/2015)... 1, 2015 Partnership includes an ... for the u niversity , s ... treatment s cale - up ... Africa , where licensees based anywhere in the world will ... technology. --> Africa , where licensees based anywhere in the ...
(Date:11/30/2015)... 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the ... C.W. Wong to its Board of Directors to replace ... with a wealth of experience as co-founder of Resverlogix, with ... --> --> Dr. Wong remarked, ... of directors. Zenith,s long standing expertise in epigenetics and the ...
Breaking Biology Technology:
(Date:10/29/2015)... Oct. 29, 2015  Rubicon Genomics, Inc., today ... distribution of its DNA library preparation products, including ... new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been ... of NGS libraries for liquid biopsies--the analysis of ... prognostic applications in cancer and other conditions. Eurofins ...
(Date:10/29/2015)... 29, 2015 Today, LifeBEAM , ... with 2XU, a global leader in technical performance ... hat with advanced bio-sensing technology. The hat will ... monitor key biometrics to improve overall training performance. ... two companies will bring together the most advanced technology, ...
(Date:10/27/2015)... SAN JOSE, Calif. , Oct. 27, 2015 /PRNewswire/ ... human interface solutions, today announced that Google has adopted ... family of touch controller solutions to power its newest ... Nexus 6P by Huawei. --> ... ecosystem partners like Google to provide strategic collaboration in ...
Breaking Biology News(10 mins):